Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy

British Journal of Cancer

Volumn 102, Issue 11, 2010, Pages 1608-1617

  Dunn, J M ^a   MacKenzie, G D ^a   Oukrif, D ^a   Mosse, C A ^a   Banks, M R ^b   Thorpe, S ^a   Sasieni, P ^c   Bown, S G ^a   Novelli, M R ^a   Rabinovitch, P S ^d   Lovat, L B ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Barrett's oesophagus; DNA ploidy; High grade dysplasia; Image cytometry; Oesophageal adenocarcinoma; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; BIOLOGICAL MARKER;

ACCURACY; ADULT; AGED; ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CELL NUCLEUS; CLINICAL ARTICLE; COHORT ANALYSIS; DNA DETERMINATION; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; MALE; PHOTODYNAMIC THERAPY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TETRAPLOIDY; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DNA, NEOPLASM; ESOPHAGUS; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERPLASIA; IMAGE CYTOMETRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOTOCHEMOTHERAPY; PLOIDIES; PROGNOSIS; RECURRENCE; TIME FACTORS;

EID: 77952889140     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605688     Document Type: Article

References (29)

1. Baldetorp B, Ferno M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Akerman M, Killander D (1992) Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 13: 577-585
2. Bocking A, Giroud F, Reith A (1995) ESACP DNA consensus in image cytometry. ACP 8: 67-74
3. Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ (2001) Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120: 1630-1639
4. Cameron AJ, Ott BJ, Payne WS (1985) The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313: 857-859
5. Chen TL, Luo I, Mikhail N, Raskova J, Raska K (1995) Comparison of flow and image cytometry for Dna content-analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast-carcinoma. Cytometry 22: 181-189
6. Esposito MJ, Fuchs A (1994) Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases. Cytometry 18: 218-222
7. Foultier MT, Vonarx-Coinsman V, de Brito LX, Morlet L, Robillard N, Patrice T (1994) DNA or cell kinetics flow cytometry analysis of 33 small gastrointestinal cancers treated by photodynamic therapy. Cancer 73: 1595-1607
8. Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG (1989) Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastro-enterology 96: 1249-1256
9. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333-1335
10. Huang Q, Yu C, Zhang X, Goyal RK (2008) Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma. BMC Clin Pathol 8: 5
11. Kaern J, Wetteland J, Trope CG, Farrants GW, Juhng SW, Pettersen EO, Reith A, Danielsen HE (1992) Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancer. Cytometry 13: 314-321
12. Lee AKC, Dugan J, Hamilton WM, Cook L, Heatley G, Kamat B, Silverman ML (1991) Quantitative Dna analysis in breast carcinomas-a comparison between image-analysis and flow-cytometry. Mod Pathol 4: 178-182
13. Leedham SJ, Preston SL, McDonald SA, Elia G, Bhandari P, Poller D, Harrison R, Novelli MR, Jankowski JA, Wright NA (2008) Individual crypt genetic heterogeneity and the origin of meta-plastic glandular epithelium in human Barrett's oesophagus. Gut 57: 1041-1048
14. Lindahl B, Ranstam J, Willen R (1994) Five year survival rate in endometrial carcinoma stages I-II: influence of degree of tumour differentiation, age, myometrial invasion and DNA content. Br J Obstet Gynaecol 101: 621-625
15. Mackenzie GD, Dunn JM, Selvasekar CR, Mosse CA, Thorpe SM, Novelli MR, Bown SG, Lovat LB (2009) Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. Lasers Med Sci 24: 729-734
16. Mackenzie GD, Jamieson NF, Novelli MR, Mosse CA, Clark BR, Thorpe SM, Bown SG, Lovat LB (2007) How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus. Lasers Med Sci 23: 203-210
17. Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML, Hart J (2001) Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 32: 379-388
18. Morgan J, Petrucci CM (2009) The effect of ALA/PpIX PDT on putative cancer stem cells in tumor side populations. In 29-6-2009 International Photodynamic Association World Congress 2009. Kessel DH (ed). Society of Photooptical Instrumentation Engineers (SPIE): Seattle, WA, USA. 738011-738019, 7380[1]
19. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak Jr MV, Nishioka N, Barr H, Marcon N, Pedrosa M, Bronner MP, Grace M, Depot M (2007) Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 66: 460-468
20. Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Westra WM, Lutzke LS, Borkenhagen LS, Dunagan K (2008) Correlation of histology with biomarker status after photodynamic therapy in Barrett esophagus. Cancer 113: 470-476
21. Rabinovitch P, Longton G, Blount P (2001) Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastro-enterol 96: 3071-3083
22. Rabinovitch PS (1994) DNA content histogram and cell-cycle analysis. Methods Cell Biol 41: 263-296
23. Reid BJ, Blount PL, Feng Z, Levine DS (2000a) Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 95: 3089-3096
24. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS (2000b) Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low-and high-risk patient subsets. Am J Gastroenterol 95: 1669-1676
25. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M (1988) Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 75: 760-763
26. Russack V (1994) Image cytometry: current applications and future trends. Crit Rev Clin Lab Sci 31: 1-34
27. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ (2009) Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 360: 2277-2288
28. Weston AP, Badr AS, Hassanein RS (1999) Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94: 3413-3419
29. Williamson WA, Ellis Jr FH, Gibb SP, Shahian DM, Aretz HT, Heatley GJ, Watkins Jr E (1991) Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 151: 2212-2216